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Abstract
Background: Multimorbidity, defined as the presence of two or more long- term condi-
tions, is increasingly common in primary care, and patients with multimorbidity may 
face particular barriers to quality of care and increased safety risks due to the com-
plexity of managing multiple conditions. Consistent with calls to directly involve ser-
vice users in improving care, we aimed to use design materials to codesign new 
interventions to improve safety in primary care.
Design: We drew on two established methods—accelerated experience- based code-
sign and the future workshop approach. We synthesized design materials based on 
research into the patient experience of safety and multimorbidity in primary care to 
enable both patients, service users and carers, and primary health- care professionals 
to propose interventions to improve care.
Results: Both patients and professionals prioritized polypharmacy as a threat to safety. 
Their recommendations for supportive interventions were consistent with Burden of 
Treatment theory, emphasizing the limited capacity of patients with multimorbidity 
and the need for services to proactively offer support to reduce the burden of manag-
ing complex treatment regimes.
Discussion & Conclusions: The process was feasible and acceptable to participants, 
who valued the opportunity to jointly propose new interventions. The iterative work-
shop approach enabled the research team to better explore and refine the suggestions 
of attendees. Final recommendations included the need for accessible reminders to 
support medication adherence and medication reviews for particularly vulnerable pa-
tients conducted with pharmacists within GP practices.
K E Y W O R D S
coproduction, long-term conditions, patient involvement, patient safety, polypharmacy, primary 
care
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1  | INTRODUCTION
Multimorbidity, defined broadly as the coexistence of two or more 
long- term health conditions,1 is an increasingly “normal” experience 
for people in later life. As well as placing patients at higher risk of mor-
bidity and mortality, multimorbidity presents challenges for patients in 
respect of continuity of care,2,3 care planning4 and self- management 
of conditions.5 Patients with multimorbidity are therefore at high risk 
of experiencing disruptions to the quality and safety of their care. It 
is also increasingly recognized that the burden of treatment itself, for 
example managing the demands of polypharmacy, may function as an 
additional barrier to quality of care, safety and good health outcomes.6 
This has led to calls for existing services to be redesigned to better 
meet the needs of complex patients living with multimorbidities, with 
this redesign directly informed by patients and patient experience.7
Patient safety in primary care settings is an under- researched area.8 
Preliminary work exploring the meaning of “safety” in primary care has 
uncovered a broad conceptualization that extends to issues such as 
trust in health services and feeling confident to speak up in consulta-
tions with health- care workers.9-11 “Safety” is therefore an issue which 
opens up wider discussions about the physical and social experiences 
of health care and health- care systems.12 There is an emerging body 
of research exploring patient involvement in addressing safety in hos-
pital settings,13,14 but there has been limited involvement in primary 
care safety. There is therefore a need to develop interventions that 
are responsive to the issues specific to primary care and sensitive to 
patient experiences.
Although guidance such as the Medical Research Council 
Framework for Complex Interventions encourages the involvement 
of stakeholders in intervention development, there is a lack of ev-
idence about the best and most efficient methods to achieve this. 
Conventional qualitative approaches such as interviews and focus 
groups are effective in capturing patient experience but do not fa-
cilitate the explicit involvement of those patients in developing novel 
interventions. To achieve this, innovative methods based around 
coproduction approaches may be most useful.15 Coproduction ap-
proaches are methodologies which explicitly involve patients in design 
and development. Such approaches are then consistent with NHS calls 
to involve patients, carers and service users collaboratively in service 
improvement,16 and to work in partnership with patients to improve 
outcomes.17 The success of approaches such as experience- based 
codesign (EBCD) have demonstrated the potential for design princi-
ples and coproduction methods to enhance patient care in a variety of 
clinical services including cancer care, emergency medicine and men-
tal health.18 In the following study, we aimed to explore whether co-
production methodologies could enhance intervention development 
and provide a mechanism to translate available evidence into patient- 
centred intervention proposals for multimorbidity and safety.
Two methods of participatory design were drawn upon for this study 
(The EPHESUS study: Empowering People to Help Speak Up about 
Safety). Firstly, we employed aspects of accelerated experience- based 
codesign (AEBCD), a method of rapid EBCD. Specifically, we wished to 
involve both public contributors and health- care professionals (HCPs) 
in the process, in recognition that involving all stakeholders can provide 
richer insights than involving patients or professionals alone.19 We also 
employed the use of a “trigger film,” a method of distilling patient in-
terviews (in this case from a national narrative interview archive) into a 
single short film that is intended to act as a “trigger” to stimulate discus-
sion and support identifying improvements. While conventional EBCD 
requires that individual films are created with the staff and patients at 
the target site, the trigger film derived from existing interviews enables 
a more rapid process, and may also be less threatening to professionals 
than appearing to present critique of “their” service.20
Secondly, we drew on the “future workshop” approach, whereby 
participants attend an initial workshop to critique a current product 
or service and propose their own ideal solutions and then attend a 
following session which presents these ideas in prototype form to en-
able iterative refinement.21 Members of the research team (SK, CS, 
PB) have previously employed this method with patients to propose 
new designs for mental health technologies.22 We aimed to explore 
whether design materials used in such workshops could be employed 
to present accessible syntheses of research findings for participants 
to work with and produce concrete suggestions for improvement. We 
therefore aimed to synthesize a “persona,” a narrative description of 
an archetypal patient,23 for participants to focus on when proposing 
improvements to current services.24 Consistent with the prototyping 
employed in the future workshop methodology, we would then use 
these suggestions to produce “scenarios”25,26 which would describe 
potential interventions in practice, to further explore the acceptabil-
ity of the suggested solutions and consider their implementation in 
practice.
To our knowledge, this is the first example of combining the two 
methods (Table 1), and the first study applying codesign methods to ad-
dress safety and multimorbidity in primary care. We drew on the iterative 
prototyping process and synthesized design materials from the future 
workshop approach. However, it is important to acknowledge that these 
materials were grounded in genuine experiences (through presenting the 
trigger film) and engage both patients and professionals together in joint 
codesign. This approach is consistent with EBCD and AEBCD.
The study therefore had the following aims:
Aim 1: To generate novel interventions, collaboratively with pa-
tients and professionals, to address safety issues for patients with 
multimorbidity in primary care.
Aim 2: To assess the feasibility and acceptability of using partic-
ipatory design approaches, including persona and scenario materi-
als, to translate research findings through codesign into intervention 
suggestions.
2  | METHODS
2.1 | Procedure
The procedure is summarized in Table 1. We conducted three work-
shops between April – July 2016, firstly, separate workshops with 
HCPs and patients to generate new ideas and then a final joint work-
shop to review prototypes of those ideas for further refinement. The 
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trigger film was presented to each group in the individual workshops 
(1 and 2), and then, the persona was provided to focus discussions. 
The outputs of workshops 1 and 2 were synthesized into prototype 
scenario interventions for critique in the final joint workshop (Figure 1).
The three researchers facilitating the workshops all had experi-
ence of working with patients with multimorbidities and primary care 
health professionals. Two (SK, RH) had experience of facilitating public 
involvement activities, and one (SK) had prior experience of facilitating 
codesign activities and was present for all three workshops.
Ethical approval is not required for involvement activities,27 but we 
sought and received ethical approval to collect and report data on the 
evaluation of the process (University of Manchester Research Ethics 
Committee 2 ref 15585, 18 February 2016).
2.2 | Sample
Nineteen patients, carers and service users (referred to by the sum-
mary term “public contributors”) who had previously contributed to 
public involvement or engagement events within the NIHR Greater 
Manchester Primary Care Patient Safety Translational Research 
Centre (Greater Manchester PSTRC) were contacted by email to ad-
vertise the workshops, and a summary of the study was presented at 
a Greater Manchester PSTRC Multimorbidity Research User Group 
(MRAG) meeting. To contact professionals, we circulated emails and 
flyers through the PSTRC professional network (a list of primary care 
health professionals across Greater Manchester who had expressed 
interest in being involved in research at the centre).
The first workshop, conducted solely with public contributors, 
was attended by 11 participants who self- identified as experiencing 
or caring for someone with multimorbidity (14 participants had ex-
pressed interest, and 11 were able to attend on the date). The second 
workshop was conducted solely with HCPs recruited through Greater 
Manchester PSTRCPSTRC networks, and was attended by five HCPs—
one GP, three pharmacists and one pharmacy dispenser (an additional 
3 GPs had expressed interest but were unable to attend on the date). 
All participants of the previous two workshops were invited to attend 
the final joint workshop. The workshop was attended by two pro-
fessionals (one pharmacist, one pharmacy dispenser) and nine public 
contributors.
2.3 | Materials
2.3.1 | Personas
Personas are intended to be archetypes of the intended users of a 
service or product, to reflect key characteristics or experiences which 
should be taken into account when improving a product or service. 
The persona also provides a shared conceptual space for different par-
ticipants to focus their suggestions. To effectively present a narrative 
synthesis of existing patient experience research into safety and mul-
timorbidity in primary care, we drew on the MAXIMUM framework.8 
This framework provides a taxonomy of events that could lead to harm 
in primary care, derived from a synthesis of qualitative studies. It also 
identifies, based on previous research, people with multimorbidities that 
may be particularly vulnerable to safety failures, for example those on 
a large number of medications or with low health literacy. We used the 
taxonomy and risk profile to create the persona of “Elaine” (Appendix 
S1). The persona was drafted initially by SK, and then reviewed by all 
members of the study team and a public involvement contributor.
2.3.2 | Scenarios
Scenarios are action- based narratives, in contrast to the charac-
ter narrative portrayed within a persona. They are therefore more 
suited than personas to encourage consideration of process and 
feasibility. In this study, we used the scenarios to prototype exam-
ple interventions, based on the outputs from workshops 1 and 2 
(Appendix S2).
TABLE  1 Elements of each method used in the study
AEBCD Future Workshop EPHESUS
Procedure Initial separate workshops for patients and 
professionals, followed by a third joint 
workshop bringing all participants 
together
Iterative—initial ideation workshop, 
followed by critique of “prototypes”
Two workshops with patients and 
professionals individually, used to create 
“prototypes” for review in final joint 
workshop
Materials “Trigger film” presented at the beginning of 
the initial workshops to stimulate 
discussion focused on patient experiences
“Persona” and “Scenario” materials to 
provide a shared discussion space for 
identifying solutions
Trigger film used at beginning of individual 
workshops, followed by persona. Scenario 
used in third workshop to present 
“prototypes” for critique
F IGURE  1 Summary of workshop procedure and content
Workshop 
One
• Public contributors only, view Trigger Film.
• Discuss persona and propose solutions
Workshop 
Two 
• Health care professionals only, view Trigger Film.
• Discussion persona and propose solutions
Workshop 
Three
• Joint workshop with both HCPs and public contributors
• Discussion of scenarios derived from synthesis of 
Workshops 1 and 2
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2.3.3 | The trigger film
While the persona and scenario were hypothetical creations to aid 
generation of solutions, the trigger film was included to establish 
that the issues being explored were grounded in the genuine ex-
periences of real people with multimorbidities. The trigger film 
was compiled by GDW from an archive of 38 narratives of patient 
experiences of multimorbidity that was collected for the national 
Healthtalk patient experiences web site, published in September 2016 
(http://healthtalk.org/peoples-experiences/long-term-conditions/
living-multiple-health-problems/topics).
2.4 | Data collection
Workshop discussions were audio- recorded for review, and research-
ers present (3 at workshop 1 and 2, 2 at workshop 3) took notes both 
during the discussions and produced field notes for shared reflection 
afterwards. We included specific time at the end of each workshop 
to review the discussions with the participants themselves, to clarify 
our observations, confirm reflections and ensure that participants 
felt all key points had been recorded. The multidisciplinary research 
team (including an academic GP (JP), quality improvement and patient 
experience researcher (LL), medical sociologists (CS, GDW), clinical 
psychologist (HS) and health service researchers (SK, RM, PB)) was 
consulted between each workshop to discuss the suggestions made 
and agree on content for the “scenarios.”
In workshops 1 and 2, after informal introductions and an over-
view of the workshop aims, we presented the trigger film and asked 
participants to reflect on the content. We then presented the persona 
and asked participants to discuss what safety issues they felt were 
apparent and which should be prioritized. We then moved onto idea 
generation, asking participants to propose solutions to the problems 
they had identified.
In workshop 3, we again completed informal introductions as 
now HCPs and public contributors were attending together. We then 
presented the scenarios, and asked participants firstly whether they 
adequately reflected their suggestions from the previous workshops. 
Secondly, we asked them to imagine the scenario in practice and 
whether it would be effective and acceptable for both patients and 
professionals.
We conducted an evaluation of the process with participants 
by inviting all attendees to complete an online survey (open for two 
months following the final workshop), in recognition of calls for more 
formal evaluation of the process and impact of patient involvement 
approaches.28 Questions from the survey are included in Appendix S3 
and asked attendees to reflect on the materials used (persona, sce-
nario, trigger film), the workshop format, and suggest improvements.
2.5 | Data analysis
We did not preselect an analysis framework for the study outputs, 
as the workshops were intended to be generative. During the analy-
sis of the discussions of workshops one and two and reflection on 
the outputs of workshop three, the core constructs from Burden 
of Treatment Theory29 appeared to most effectively capture the 
study discussions and outputs. We therefore report the outputs of 
the workshops in reference to this model, but this was applied ret-
rospectively and not used to guide content during the workshops 
themselves.
3  | RESULTS
We present results firstly of the workshops themselves, reporting 
the discussions around safety and suggested interventions (Aim 1). 
Secondly, we reflect on the process of the workshops themselves and 
report results of the evaluation (Aim 2).
3.1 | Aim 1: What interventions to improve safety 
for people with multimorbidity in primary care were 
proposed?
The emergent findings, both in terms of the kind of threats to safety 
that were prioritized and the corresponding interventions required 
to effectively improve care for patients with multimorbidities, can be 
understood within Burden of Treatment theory (BoT). BoT focuses 
on relationships between patients, their social networks and formal 
services, and considers the capacity of individuals and their networks 
to perform the work of managing illness with a focus on the need for 
collective action and compensating for the “burden” of complex treat-
ments themselves. The theory is drawn on here to firstly present the 
results from the individual workshops (workshop 1, public contributor 
only, and workshop 2, HCP only, using the “persona” material) and 
secondly from the joint workshop (workshop 3, using the “scenario” 
materials.)
3.1.1 | Workshops 1 and 2: Outputs
There was consensus in and between the public contributor work-
shop and the HCP workshop about the risks to safety for patients 
such as “Elaine,” with medication safety as the primary focus of dis-
cussion. The trigger film had focused on medication management 
(which had emerged as a significant safety issues in the interview); 
however, patients themselves emphasized that this should not be re-
strictive and raised issues that had not been covered in the film (such 
as mental health). Medication management was focused on however 
in terms of proposing interventions that could address identified 
problems, which may reflect that it was considered the most “action-
able” safety issue.
Given the consensus across workshops 1 and 2 regarding both 
which threats to safety should be addressed and possible solutions, 
we present the results together in Table 2.
There was some difference in which solutions were discussed 
more between the two groups, with public contributors focusing 
on their sphere of influence (the home environment and navigating 
services) while HCPs focused on theirs (actions during or arranging 
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consultations, communication both with patients and with other pro-
fessionals). The patient group emphasized the following:
1. The support needed in terms of everyday management at home 
given the demanding nature of multimorbidity, described by one 
public contributor as: “…to have multiple conditions and to have 
to look after someone with multiple conditions is a full-time 
job…” This would include support to remember complex med-
ication schedules, but also encompassed the importance of 
managing side-effects, particularly the need to prioritize with 
the patient which conditions should be focused on and which 
side-effects were least tolerable.
2. Public contributors also suggested that a way of sharing this infor-
mation across services (eg from general practice to pharmacy) was 
necessary, as patients would struggle to remember the information 
themselves or were required to take responsibility themselves, fur-
ther adding to the burden of management. One patient commented 
that “the linkage between them (healthcare professionals) is hugely 
inefficient and you are running round in circles.”
The professionals also discussed these issues, and public contribu-
tors did discuss the need for proactive, supportive and sensitive service 
provision, but the solutions proposed by the HCPs focused more on the 
latter. The HCPs spoke particularly about the need for services to ex-
plicitly offer support to patients and provide opportunities for them to 
discuss their concerns, as limited time in consultations and lack of con-
tinuity of care meant that the onus was on the patient to initiate such 
conversations, but they may feel unable to do so.
Consistent with BoT theory, all participants’ discussion therefore 
encompassed a holistic understanding that recognized Elaine’s health 
and condition management as tied to her personal and social context. 
The discussions that emerged for both groups of participants can be 
understood within the concept of “capacity,” which is fundamental to 
the BoT model. This focuses on the resources available—or lacking—for 
people managing illness and the demands on their capacity by made 
complex treatment regimes (such as those faced by patients with mul-
timorbidities). In particular, both patients and HCPs reflected on the 
limited capacity that “Elaine” had, both in terms of psychological re-
sources (memory problems, possibly low health literacy, anxiety) and 
physical resources (fatigued, largely housebound, socially isolated) in 
comparison with an increasingly complex treatment schedule which 
required considerable organization and also proactive communication 
with professionals.
However, discussion did not focus solely on “Elaine” herself, but, 
again consistent with BoT theory, considered the patient within their 
wider context of relationships both socially, with family members, 
and with formal health services and professionals. This included rec-
ognition of the beliefs or norms about help- seeking and responsibil-
ity that impacted on utilization, for example Elaine’s reluctance to 
“bother” family members and even professionals. In workshop 2, this 
prompted a sensitive discussion of perceptions of responsibility dis-
tributed across HCP networks (“I focus on what I do [checking the 
medications] but not what I’m not doing [asking the patient about 
their experience and any side effects]”) and of how interactions 
with patients could be steered towards limiting conversation that 
avoided exploring safety risks (“You can ask in a way that they say 
no everything’s ok”).
Following these discussions and prior to workshop 3, the sugges-
tions from workshops 1 and 2 were synthesized into three prototype 
interventions (Appendix S2):
1. Scenario 1 “In The Practice”: describing a targeted database 
review, which calls in patients with multimorbidity to discuss 
their medications, paying specific attention to ensuring health 
information is understood and patient priorities are sought.
2. Scenario 2 “In The Pharmacy”: describing a pharmacist offering 
additional support for medication management (such as dosette 
boxes) by calling in patients who have not collected prescrip-
tions and asking about support available from family or 
friends.
3. Scenario 3 “In The Home”: describing a “Medication Diary” that 
can be used to organize medication schedules and provide 
prompts to attend reviews, and could be shared with health 
professionals.
TABLE  2 Summary of prioritized safety issues and suggestions to address them
Priority risk to safety identified Suggested solutions
Understanding and management of complex medication schedule, when 
patient struggles with memory problems and potentially low health 
literacy
• Support to adhere to schedule—reminders, alerts.
• Explanation by health professionals that is tailored to helping patient 
understand.
• Support to share information across different professionals, for 
example both with GPs and pharmacists
Patient particularly vulnerable—older, multiple conditions requiring 
different medications, may be suffering from mental health problems 
such as dementia or depression/anxiety, in dual caring role with 
husband
• Review databases to flag “at risk” individuals such as those over 70 on 
multiple medications or with comorbidities, and provide those 
patients with a review to provide additional support
Patient isolated, struggles to organize follow- up appointments or to 
know when to contact services. Influence of norms and lack of 
continuity of care with a trusted professional meaning she worries 
about “bothering” the health professionals or is unsure who to ask for 
help
• Services must be proactive in offering support
• Identify whether other people in patient’s network (eg family carers) 
could be included on reminder/appointment notifications
• Structured assessment to help elicit concerns, particularly around 
side-effects of medications and potential adverse interactions
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3.1.2 | Workshop 3: Outputs
Again consistent with BoT theory, discussion of the scenarios focused 
on the work that was required to effectively manage illness and miti-
gate against safety risks. Given the limited capacity of people such as 
“Elaine,” intervention suggestions were critiqued based on how much 
they compensated for her lack of capacity (eg did they make remem-
bering medication schedules easier, taking into account her memory 
difficulties?) and how much they drew on the resources of others to 
help distribute this effort and collectively manage her safety. In re-
lation to the medication diary, it was emphasized that this must go 
beyond merely monitoring and not appear to be collection of infor-
mation for the service alone, but should be part of a review process 
where patients have the opportunity to reflect on the information 
with a HCP, or should help to overcome capacity issues by providing 
an accessible means of supporting “Elaine” to adhere to her medica-
tion schedule. The idea of an automatic reminder to help patients take 
medications was therefore reviewed favourably, but using the diary 
to organize reviews and to share with professionals was considered 
too burdensome.
One novel focus in workshop 3 (compared to the previous work-
shops) was on the meaning and shared understanding (between pa-
tient and HCP) that was considered vital to underpin any effective 
intervention, with all participants emphasizing that patients must be 
convinced of the value of any activities if they are to engage with them 
and they are to be effective. This is consistent with the importance of 
“sense- making” in BoT theory, referring to the work of understand-
ing treatments themselves and communicating needs between actors 
(patient and professional). Sense- making is considered an essential 
component in mobilizing action to enact the work of multimorbidity 
management. In relation to the enhanced review suggestions, this 
meant ensuring that reviews were not a “box ticking exercise” and that 
the HCP conducting the review was both in a position to directly in-
fluence treatment (eg changing prescriptions) and able to effectively 
negotiate these outcomes with the patient. This led to discussion that 
the pharmacist in Scenario 2 would have to communicate separately 
with the patient’s practice or the onus would be on the patient to 
request changes, and consequently a pharmacist embedded within 
practices may be better placed. Participants also emphasized, again 
consistent with the importance of sense- making that communication 
should go beyond checks on understanding of information to commu-
nicating the benefits of any changes and being responsive to patient 
concerns. Both patients and professionals agreed this would require 
dedicated, protected time to enable issues to be explored.
At the end of workshop 3, the initial ideas represented in the sce-
nario materials had been refined into two specific suggestions:
1. An intervention that provided automatic reminders to support 
adherence to a medication schedule, and which potentially could 
also be used to easily communicate the patients’ medication 
profile to other professionals and capture patient feedback to 
inform future reviews without providing significant monitoring 
burden (eg a wearable technology or app).
2. An enhanced review provided by a pharmacist embedded within 
the patients’ practice (who would therefore be better placed to co-
ordinate with the patients’ GP), ensuring that the goal of the review 
was communicated clearly to the patient, and the review was col-
laborative, with the patients’ priorities sought and integrated into 
the treatment plan.
3.2 | Aim 2: Evaluation of the feasibility and 
acceptability of the process to all stakeholders
Participants were positive about the overall experience. Both pro-
fessionals and patients emphasized the value of the joint workshop, 
which provided what was considered to be a rare opportunity to 
openly discuss services with each other.
The online evaluation survey was completed by 7 participants, 4 
patients and 3 HCPs. Only one respondent (a patient) attended the 
joint workshop as well. There were seven respondents, one female, 
with an average age of 54. Of the four public contributors, two identi-
fied as a patient and two as a carer. All were White British except one 
British Asian (a HCP). The workshop itself was rated as useful (mean 
rating of 5.9, with 1 being not at all useful and 7 being extremely use-
ful), and the experience was rated as positive (mean rating of 5.3, with 
1 being very poor and 7 being very good).
Survey ratings indicated an ambivalent response to the materials, 
with both the trigger film and the persona/scenario rated as mod-
erately useful (mean rating 3.7 for the persona/scenario and 4.2 for 
the trigger film, with 1 being not at all useful and 7 extremely use-
ful). However, this reflects that two of the respondents (both patients) 
did not find the materials useful at all, whereas the others rated them 
more highly. Telephone interviews with three workshop participants—
all patients—added further insights into these matters. While all of 
those interviewed felt that the trigger film and the persona were use-
ful and informative, difficulties in hearing the film were reported as 
problematic.
Discussion by patients of their own experiences tended to domi-
nate the discussion in workshops 1 and 3, at the expense of in- depth 
discussion of the materials and focusing on proposing ideas to tackle 
the problems identified. However, responses to the telephone inter-
views underlined that such exchanges of personal experiences are 
seen as informative and are highly valued. Other patients however felt 
that greater balance was needed between discussion of the materials 
and personal reflections. Two of the patient respondents to the survey 
commented that “more disciplined” facilitation was needed, comment-
ing that “Elaine’ [the persona] was an opportunity for discussion which 
was largely lost in participants’ wishes to elaborate on their own” and 
“Persona should have been more useful, but her problems were lost in 
too much detail in participants’ personal experiences.” These partici-
pants were those who had rated the material as less useful, indicating 
the problem with these was the facilitation and maintaining focus on 
them rather than dislike of the materials themselves.
From the research team perspective, the persona was well received. 
Comments from participants in workshop 1 indicated it was identified 
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with and felt to be representative of genuine experience, with com-
ments including “This is me and my husband on a daily basis” and “This 
could be my mother- in- law this is describing.” The persona provided 
a useful mechanism for challenging ideas both for facilitators and for 
patients to explore with each other, commenting “Would that work for 
Elaine though?” The persona seemed to be particularly powerful for the 
professional group and prompted a focus on considering the “whole 
person” experience that the attendees said they may not have con-
sidered otherwise. It also appeared to help HCP participants consider 
different professional perspectives, with one respondent commenting: 
“It was interesting to discuss the persona with other healthcare profes-
sionals, particularly the GP, who approached the persona from a medi-
cal perspective, which differed from a pharmacy perspective.”
Although discussion in the joint workshop was focused less on the 
scenario materials, the scenarios again proved useful for the research 
team, specifically by providing a means of explicitly checking whether 
the team’s understanding of the suggestions was correct and prompt-
ing participants to critique their original ideas. For example, the med-
icines diary which had been suggested in workshop 1 was reviewed 
negatively once the scenario was considered, with participants com-
menting that the diary was an additional burden (as it must be com-
pleted and remembered by the patient) and that it was unclear how it 
could help encourage interactions with HCPs. This led to refinements, 
considering instead how patients could be helped to remember and 
report medication use without cognitive cost to themselves, and re-
newed focus on the responsibility of professionals to be proactive in 
offering opportunities to discuss medications.
The scenarios also appeared to prompt a focus on “sense- making” 
(understanding treatment and sharing this understanding) which was 
less evident in the first two workshops. It is possible that imagining 
the interventions in practice helped the respondents to consider mo-
tivating factors that would impact on its effectiveness, or this may 
have emerged due to the joint format with attendees considering 
whether there is typically shared understanding between patients and 
professionals.
Although the joint workshop was overwhelmingly attended by pa-
tients compared to HCPs and discussion of patients’ own experiences 
dominated, it was nevertheless evident that the joint format enabled 
a shared understanding to develop. The pharmacists for example de-
scribed their responsibilities in checking medicines and the conse-
quences of medicine errors, and patients commented “That’s a lot of 
pressure for you,” indicating empathy and perspective- sharing with the 
HCPs. The patient attendees also in some cases referred to their pro-
fessional experience (as a social worker and as a care home worker), 
and the HCP attendees referred to their own experience as patients, 
again indicating that the process enables participants to share perspec-
tives and move beyond restrictive “us and them” conceptualizations.
4  | DISCUSSION
The present study had two aims—firstly, to codesign new interven-
tions with both patients and professionals to improve safety for 
people with multimorbidity in primary care, and secondly, to assess 
the feasibility and acceptability of the codesign process and materials 
to achieve this. We will firstly discuss how the study met each of these 
aims, secondly address limitations and finally provide conclusions.
4.1 | Aim 1: Producing codesigned interventions to 
improve safety in primary care
The workshop process produced two final intervention suggestions. 
Common to both is a recognition of the need to compensate for the 
reduced capacity of vulnerable patients with comorbidities and for 
organizations to be proactive in providing opportunities to interact 
with HCPs. Participants furthermore emphasized the importance of 
providing not only functional mechanisms to achieve this, but ensur-
ing that the purpose and value of such activities is clearly communi-
cated. More broadly, the findings contribute to a growing literature 
that emphasizes “safety” as not merely the avoidance of error but a 
need for care which is more holistic and more responsive to patient 
priorities. Our findings are consistent with research demonstrating 
that conceptualizations of safety in primary care go beyond techni-
cal measures and encompass relational aspects of care that must be 
 negotiated between patient and professional, requiring enhanced 
communication and sensitivity to the patients’ trust in professionals 
and treatments.8,11
The outputs are also consistent with the finding that patients do 
not typically have the opportunity to discuss their own needs and 
preferences regarding medication management,30 particularly pa-
tients with complex and compounded conditions,31 and consequently, 
mechanisms are required which both provide opportunities for pa-
tients to be heard and which support professionals to effectively elicit 
and incorporate patient views into treatment plans.
The limited capacity of individuals with multimorbidity makes 
self- management particularly challenging,32 and both patient and 
professional participants focused on the need for interventions which 
compensated for, rather than added to, this individual burden. The 
study outputs were consistent with the Burden of Treatment theory 
proposed by May and colleagues,29 and demonstrate the value of this 
theory to understanding, and potentially improving, patient safety in 
primary care. The suggestions are intended to offer prototype ideas 
for further development, which capture key insights from patients and 
professionals regarding the need to address treatment burden and 
enhance communication. The ideas are consistent with the ARIADNE 
principles for managing multimorbidity in practice33 and the core el-
ements (enhancing communication, recognizing patient needs holis-
tically and reducing burden of treatment) could be incorporated into 
broader interventions such as care planning.
It should be recognized that patients will have different needs and 
preferences regarding multimorbidity management,34 and not all will 
perceive a “burden.” Participants in the workshops were clear that 
different needs must be accommodated, and a key recommendation 
from the workshops was to actively communicate with patients to 
avoid making assumptions about their capacity or priorities. However, 
while treatment burden may not be the primary issue in management 
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for all patients in terms of their health outcomes, it may be the priority 
issue in terms of perceptions of managing safety in treatment, with the 
workshop outputs supporting the idea that burden of polypharmacy 
management was considered an especially salient safety threat.
Recent NICE guidance for management of patients with multimor-
bidity recommends that care is responsive to patient preferences, but 
the present study enabled us to more specifically explore with both 
patients and professionals what this could look like in practice. This 
led to recognition that both structural (dedicated appointments) and 
relational (sensitive communication, trust) space are essential for such 
preferences to be genuinely shared. Participatory design approaches 
therefore appear useful for understanding how recommendations 
must not only “look” but “feel” in practice.
4.2 | Aim 2: Assessing the feasibility and 
acceptability of the codesign methods
The process proved to be feasible and acceptable to all stakeholders 
(patients, HCPs and researchers themselves), although three issues 
emerged, firstly regarding recruitment of attendees, secondly the ac-
cessibility of the materials and thirdly involving the facilitation burden 
of the format (these are discussed below in “Limitations”).
Involving both patients and HCPs, consistent with AEBCD, led to 
a rich understanding of the barriers to improving safety in primary 
care, with both sets of attendees providing a holistic account that 
emphasized the interaction between patients’ capacity, the demands 
of their treatment and the opportunities for intervention in primary 
care. The final outputs were the product of consensus between all 
participants.
The structure of the workshops, whereby solutions proposed by 
each group were used to create prototype interventions for review 
in the final workshop, drawn from the future workshop approach, 
demonstrated its value in enabling more iterative design than a single 
consultation would have allowed. The final workshop and review of 
the prototypes, in the form of scenarios, enabled us to refine the ideas, 
challenge our understanding of the suggestions and further synthesize 
the suggestions into practical concepts.
The “blending” of two methods (AEBCD and future workshops) 
was successful in enabling us to integrate desired elements from each. 
Adoption of different methods can be a challenge to fidelity and risk 
“diluting” key ingredients. We have attempted therefore to clearly de-
scribe and justify the elements chosen from each. It is also import-
ant to clarify that the workshop process outlined here is not intended 
to be a substitute for more sustained programmes of participation in 
improvement initiatives. The workshops are not suggested as a re-
placement for the need for continued user input to fully develop and 
evaluate the ideas. The study however demonstrates the feasibility 
of the methods to provide an early- stage option for preliminary idea 
generation and refinement, enabling codesign which could be used 
to support later coproduction. The use of design materials provided 
a method for translating research findings into accessible patient ex-
perience resources. The study provides further support to calls for 
greater use of participatory design approaches to support intervention 
development21 and demonstrates the usefulness of such methods to 
design interventions addressing safety and multimorbidity.
4.3 | Limitations
There are three key limitations to the study. Firstly, we struggled 
to recruit as many HCPs as patients. The unbalanced numbers, 
particularly for the joint workshop, may have contributed to the 
discussion being dominated by patients discussing their own expe-
riences. However, there was consensus reached around the refine-
ments needed to the prototype interventions, and the HCP- only 
workshop outputs were consistent with those from the public con-
tributor workshop. We did consider additional data collection with 
health professionals through individual surveys/semi- structured 
interviews, but felt that this would miss the crucial interactive com-
ponent of the workshops. Although the number of patients to pro-
fessionals in the final joint workshop was unbalanced, the outputs 
suggest that the mix of participants had the desired effect of en-
couraging multiple perspectives to be considered. A greater number 
of professional attendees nevertheless may have enabled more di-
vergent views to be captured. We particularly lacked GP attendees 
however, which may have influenced the final outputs, although 
patients (and not only pharmacists themselves) suggested the role 
of community pharmacy in providing support.
Recruitment of the public contributors also had limitations. We 
are in agreement with arguments that public contributors should 
not be judged on “representativeness”,35 but we do acknowledge 
that lack of diversity in the attendees means that issues of particular 
relevance to other groups (such as BAME groups) may have been 
neglected. This also relates to the second limitation, whereby the 
use of personas and scenarios to make material more accessible 
introduced a different barrier to access by limiting attendance to 
people who can read English. Some patients also expressed difficul-
ties hearing both the video and during the workshops. While design 
materials can help in making complex concepts more accessible, 
the accessibility of those materials themselves must be considered, 
for example whether they are appropriate for people with hearing 
difficulties (although using a variety of materials, including visual 
prompts, may overcome this).
The final key challenge was around facilitation, as it was difficult 
to focus public contributors on the materials rather than on discus-
sion of their own experiences. Discussion of personal experience 
was not outside the remit of the workshop and we did not wish to 
exclude such personal reflections, but we had hoped that the work-
shops would be a space to consider solutions rather than generate 
new problems. This reflects the challenge of effective facilitation in 
such settings, where researchers must be sensitive to issues that 
emerge and provide space for expression, but find a balance be-
tween this expression and a focus on the tasks. Involving patients 
in research and service improvement is a complex task, and as ap-
proaches to involving patients also become more complex, it is likely 
that explicit training and support of researchers to manage involve-
ment activities successfully will be essential.36
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Finally, there was a limited response to the survey evaluation. 
More substantial evaluation, for example participant interviews, would 
be helpful to fully explore participants’ experiences and suggestions 
for improvement. The positive findings nevertheless provide “proof of 
concept,” and add to the emerging literature on the value of partici-
patory approaches to improving patient safety, and demonstrate the 
feasibility and acceptability of integrating the methods.
5  | CONCLUSIONS
The findings demonstrate that patients and professionals have a 
shared vision for improving primary care for patients with multi-
morbidity, perceiving that safety issues may arise from neglecting 
the burden of treatment on patients with limited resources for self- 
management. Focusing on the challenge of polypharmacy, partici-
pants emphasized the need for shared effort, with services helping to 
compensate for the demands of both the patients’ multiple illnesses 
and the complexity of their treatment. The study demonstrates the 
value of bringing patients and professionals together to directly con-
tribute to codesign.
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